Rapports de recherche, comptes rendus, lettres à l'éditeur, working papers (1)
  1. 1. Lapouge, G., & Blanpain, C. (2008). Therapeutic applications of skin stem cells. Stem Book Harvard Stem Cell Institute.
    2.   Participations à des congrès et colloques internationaux (9)
  2. 1. Lapouge, G., Kass, Y. K., & Blanpain, C. (2010). Hair follicle stem cells and interfollicular epidermis are competent to initiate squamous skin tumors. Paper session presented at European Workshop on Skin Stem Cells (Cambridge, UK).
  3. 2. Lapouge, G., & Céraline, J. (2007). Role of carboxy-terminal end truncated androgen receptor in prostate cancer. Poster présenté à la conférence EuCC (Strasbourg, France).
  4. 3. Lapouge, G., Erdmann, E., Bergerat, J.-P., & Céraline, J. (2006). Transcriptional activities of a carboxy-terminal end truncated mutant androgen receptor : Impact on prostate cancer progression. Poster présenté à la conférence ARTP (Paris, France).
  5. 4. Lapouge, G. (2006). Androgen receptor mutations in prostate cancer. Paper session presented at IRCAD (Strasbourg, FRANCE).
  6. 5. Lapouge, G., Marcias, G., Erdmann, E., Kessler, P., Bergerat, J.-P., & Céraline, J. (2006). Specific functions of a carboxy-terminal end truncated androgen receptor mutant in prostate cancer cells. Poster présenté à la conférence Androgens 2006 (Cambridge, UK).
  7. 6. Lapouge, G., Marcias, G., Erdmann, E., Serra, S., Kessler, P., Bergerat, J.-P., & Céraline, J. (2006). Specific properties of a carboxy-terminal end truncated Androgen Receptor detected in hormone refractory prostate cancer. Poster présenté à la conférence Fifth International Symposium on Hormonal Carcinogenesis (La Grande Motte, France).
  8. 7. Lapouge, G. (2005). New properties of a carboxy-terminal end truncated Androgen Receptor detected in hormone refractory prostate cancer. Paper session presented at European Cancer Center Symposium (Basel, Suisse).
  9. 8. Lapouge, G., Erdmann, E., Jagla, M., Monge, A., Klein-Soyer, C., Bergerat, J.-P., & Céraline, J. (2005). Specific transcriptional activities of carboxy-terminal end truncated androgen receptor detected in hormone refractory prostate cancer. Poster présenté à la conférence FEBS-IUBMB Conference (Budapest, Hongrie).
  10. 9. Lapouge, G. (2005). Physiopathology of the androgen receptor in prostate cancer. Paper session presented at IRCAD (Strasbourg).
    11.   Brevets (1)
  11. 1. Bondue, A., Lapouge, G., & Blanpain, C. (2008). Mesp1 acts as a master regulator of multipotent cardiovascular progenitor specification.
    12. << Précédent 1 2 3 Suivant >>